Drug-induced chronic hepatitis and cirrhosis. 1979

W C Maddrey, and J K Boitnott

UI MeSH Term Description Entries
D007538 Isoniazid Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. Isonicotinic Acid Hydrazide,Ftivazide,Isonex,Isonicotinic Acid Vanillylidenehydrazide,Phthivazid,Phthivazide,Tubazide,Acid Vanillylidenehydrazide, Isonicotinic,Hydrazide, Isonicotinic Acid,Vanillylidenehydrazide, Isonicotinic Acid
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008750 Methyldopa An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent. Methyldopate,alpha-Methyldopa,Aldomet,Alphamethyldopa,Apo-Methyldopa,Dopamet,Dopegit,Dopegyt,Dopergit,Hydopa,Meldopa,Nu-Medopa,Sembrina,alpha-Methyl-L-Dopa,Apo Methyldopa,Nu Medopa,alpha Methyl L Dopa,alpha Methyldopa
D009336 Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.
D010114 Oxyphenisatin Acetate A laxative that undergoes enterohepatic circulation. It may cause jaundice. Dioxyphenylisatin,Oxyphenisatin,Phenolisatin,Acetfenolisatin,Diasatine,Isocrin,Oxyphenisatine,Acetate, Oxyphenisatin
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D005260 Female Females
D006221 Halothane A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178) 1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides

Related Publications

W C Maddrey, and J K Boitnott
January 1993, Gastroenterologie clinique et biologique,
W C Maddrey, and J K Boitnott
October 2010, The Journal of infection,
W C Maddrey, and J K Boitnott
October 1978, Lakartidningen,
W C Maddrey, and J K Boitnott
December 1980, Springer seminars in immunopathology,
W C Maddrey, and J K Boitnott
April 1988, Bailliere's clinical gastroenterology,
W C Maddrey, and J K Boitnott
December 1977, Medizinische Klinik,
W C Maddrey, and J K Boitnott
March 1973, The American journal of digestive diseases,
W C Maddrey, and J K Boitnott
January 1987, La Revue de medecine interne,
W C Maddrey, and J K Boitnott
January 1984, Hepatology (Baltimore, Md.),
W C Maddrey, and J K Boitnott
February 2002, Seminars in ultrasound, CT, and MR,
Copied contents to your clipboard!